CPEB4 and hepatocellular carcinoma: Tsai and colleagues also collected and analyzed data from 49 human HCC samples, where they found CPEB4 to be mostly overexpressed in early stages of HCC and greatly decreased in late stages, suggesting CPEB4’s role at later stages of HCC intends to facilitate HCC progression, manifesting a complicated biphasic role in tumorigenesis.